Fradelos Evangelos C, Prapa Paraskevi Maria, Tsaras Konstantinos, Papagiannis Dimitrios, Chatzi Maria, Papathanasiou Ioanna V, Guillen Bob, Saridi Maria, Souliotis Kyriakos
Department of Nursing, University of Thessaly, Larissa, Greece.
Sotiria Chest Diseases Hospital of Athens, Athens, Greece.
Adv Exp Med Biol. 2023;1425:191-197. doi: 10.1007/978-3-031-31986-0_18.
The aim of this study was to investigate the psychometric properties of the Greek version of FACIT-COST, as well as to assess the levels of financial distress of patients suffering from lung cancer in relation to their quality of life and lung cancer symptom burden. This was a cross-sectional quantitative study. A self-assessment instrument was used to gather the data. The study involved 120 lung cancer patients who were treated using chemotherapy in a day clinic of a General Hospital in Athens. Data were collected with the COST-FACIT-v2 (used to assess the patients' financial toxicity), The 12-item Health Survey (SF-12), and functional Assessment of Cancer Therapy-Lung Symptom Index Questionnaire-7 items-version 4 (FACIT-FACT-LCS). Descriptive statistics as well as exploratory factor analysis performed all the statistical analyses, which were conducted using IBM SPSS Statistics 25 and had p-values with a significance level of 0.05. The majority of the participants were male (68.3%), married or cohabitated (81.3%), and had been diagnosed with microcell cancer (90%). The factor analysis resulted in one factor that interpreted 35% of the total variance. FACT-L (r = 0.365, p < 0.001), physical component SF-12 (r = 0.184, p = 0.045), and mental health component SF-12 (r = 0.268, p = 0.003) were positively correlated to FACIT-OST, as expected. The Greek validated COST-FACIT-v2 is a reliable tool in providing rapid assessment of cancer patients' level of financial distress.
本研究的目的是调查希腊版FACIT-COST的心理测量特性，并评估肺癌患者的财务困境水平与其生活质量和肺癌症状负担之间的关系。这是一项横断面定量研究。使用自我评估工具收集数据。该研究纳入了120名在雅典一家综合医院日间诊所接受化疗的肺癌患者。使用COST-FACIT-v2（用于评估患者的财务毒性）、12项健康调查（SF-12）和癌症治疗功能评估-肺癌症状指数问卷-7项第4版（FACIT-FACT-LCS）收集数据。描述性统计以及探索性因素分析进行了所有统计分析，这些分析使用IBM SPSS Statistics 25进行，p值的显著性水平为0.05。大多数参与者为男性（68.3%），已婚或同居（81.3%），并被诊断为微细胞癌（90%）。因素分析产生了一个解释总方差35%的因素。正如预期的那样，FACT-L（r = 0.365，p < 0.001）、SF-12身体成分（r = 0.184，p = 0.045）和SF-12心理健康成分（r = 0.268，p = 0.003）与FACIT-OST呈正相关。经验证的希腊版COST-FACIT-v2是一种可靠的工具，可用于快速评估癌症患者的财务困境水平。
